What is Zacks Research's Forecast for PAHC FY2026 Earnings?

Key Points

• Zacks Research has increased its FY2026 earnings per share estimate for Phibro Animal Health to $2.19, up from a previous forecast of $2.18, while the current consensus estimate stands at $1.95 per share.
• Phibro Animal Health recently declared a quarterly dividend of $0.12 per share, reflecting an annualized yield of 1.7% with a payout ratio of 61.54%.
• The company's stock is currently rated as a "Hold" with a consensus target price of $24.40, following various upgrades from multiple financial analysts in recent weeks.

Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) - Stock analysts at Zacks Research lifted their FY2026 earnings estimates for Phibro Animal Health in a research report issued on Wednesday, August 6th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $2.19 for the year, up from their previous forecast of $2.18. The consensus estimate for Phibro Animal Health's current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Phibro Animal Health's Q4 2026 earnings at $0.69 EPS, Q4 2027 earnings at $0.64 EPS and FY2027 earnings at $2.34 EPS.

A number of other research firms also recently commented on PAHC. BNP Paribas raised shares of Phibro Animal Health to a "hold" rating in a research report on Monday, June 16th. Wall Street Zen raised shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. BNP Paribas Exane raised shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 target price for the company in a report on Monday, June 16th. JPMorgan Chase & Co. upgraded Phibro Animal Health from a "neutral" rating to an "overweight" rating and raised their price objective for the company from $25.00 to $35.00 in a research report on Monday, July 7th. Finally, Morgan Stanley set a $26.00 price target on shares of Phibro Animal Health and gave the company an "equal weight" rating in a report on Wednesday, June 25th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $24.40.

Phibro Animal Health Stock Up 4.0%

Shares of PAHC stock traded up $1.13 during trading hours on Friday, hitting $29.68. 337,361 shares of the company's stock traded hands, compared to its average volume of 259,591. The stock has a market cap of $1.20 billion, a price-to-earnings ratio of 38.05, a PEG ratio of 0.47 and a beta of 0.80. The company has a quick ratio of 1.23, a current ratio of 2.91 and a debt-to-equity ratio of 2.67. The stock's fifty day simple moving average is $27.06 and its two-hundred day simple moving average is $23.57. Phibro Animal Health has a 12-month low of $16.16 and a 12-month high of $31.80.

Hedge Funds Weigh In On Phibro Animal Health

Several large investors have recently made changes to their positions in the stock. Man Group plc purchased a new position in Phibro Animal Health during the 4th quarter worth $501,000. GAMMA Investing LLC lifted its position in Phibro Animal Health by 2,011.4% during the first quarter. GAMMA Investing LLC now owns 36,718 shares of the company's stock valued at $784,000 after buying an additional 34,979 shares in the last quarter. Lazard Asset Management LLC lifted its position in shares of Phibro Animal Health by 2,739.7% during the fourth quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock worth $34,000 after purchasing an additional 1,589 shares in the last quarter. Nuveen Asset Management LLC lifted its position in shares of Phibro Animal Health by 21.4% during the fourth quarter. Nuveen Asset Management LLC now owns 588,001 shares of the company's stock worth $12,348,000 after purchasing an additional 103,618 shares in the last quarter. Finally, Principal Financial Group Inc. raised its holdings in Phibro Animal Health by 2.6% in the first quarter. Principal Financial Group Inc. now owns 101,356 shares of the company's stock valued at $2,165,000 after acquiring an additional 2,573 shares in the last quarter. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 24th. Stockholders of record on Wednesday, September 3rd will be issued a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 1.6%. The ex-dividend date is Wednesday, September 3rd. Phibro Animal Health's dividend payout ratio is currently 61.54%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.